| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5647388 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 7 Pages |
Abstract
Icatibant self-administration shortened attack duration and time to treatment, with no difference in safety or local tolerability compared with HCP-administration. These findings support icatibant as an effective on-demand option for home-based treatment.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Iris M. MD, William R. MD, Shelley PhD, Huamin Henry MD, PhD, Timothy J. DO, Niki S. BA, Matthew I. MS, Julie CCRC, Marc A. MD, MS, Bruce L. MD, Aleena MD,